Eiger BioPharmaceuticals Inc $ 10.17 -0.27 (-2.59%)
Volume:
147,428
Avg Vol (1m):
338,688
Market Cap $:
330.85 Mil
Enterprise Value $:
237.94 Mil
PE Ratio:
0.00
PB Ratio:
3.27
Financial Strength | 4/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 3.87 | ||
Debt-to-Equity | 0.35 | ||
Debt-to-EBITDA | -0.55 | ||
Piotroski F-Score | 3 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -97.84 | ||
ROA % | -56.66 | ||
ROC (Joel Greenblatt) % | -2804.52 | ||
3-Year EBITDA Growth Rate | 27.7 | ||
3-Year EPS without NRI Growth Rate | 26.8 |
EIGR
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 3.27 | ||
EV-to-EBIT | -3.99 | ||
EV-to-EBITDA | -4.03 | ||
Current Ratio | 6.23 | ||
Quick Ratio | 6.23 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -43.2 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 3.27 | ||
Earnings Yield (Greenblatt) % | -25.06 |